CLINICAL_TRIALS
ClinicalTrials.gov record update
A Pilot Study of Olaparib and Durvalumab in Patients With Metastatic Triple Negative Breast Cancer
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03544125
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:37:56.028583+00:00
- Published At
- 2020-11-20T00:00:00+00:00
- Record Updated At
- 2020-11-20
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Anatomic Stage IV Breast Cancer AJCC v8", "Estrogen Receptor Negative", "HER2/Neu Negative", "Progesterone Receptor Negative", "Prognostic Stage IV Breast Cancer AJCC v8", "Triple-Negative Breast Carcinoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-11-20"- protocolSection.identificationModule.nctId
"NCT03544125"- protocolSection.identificationModule.officialTitle
"A Pilot Study of Olaparib and Durvalumab in Patients With Metastatic Triple Negative Breast Cancer"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.